ProShares - S&P 500 Ex-Health Care ETF
SPXV
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management - Global
- Address
- 7501 Wisconsin Avenue, Suite 1000E Bethesda MD United States of America 20814
- IPO Date
- Sep 24, 2015
- CIK
- 0001174610
- Website
- proshares.com
- Similar Companies
- Business
- ProShares S&P 500 Ex-Health Care ETF (SPXV) is an exchange-traded fund that seeks investment results, before fees and expenses, that correspond to the performance of the S&P 500 Ex-Health Care Index. The fund invests principally in equity securities, including common stocks of public companies comprising the index, which measures the performance of companies included in the S&P 500 Index excluding those classified in the health care sector; it employs a replication or representative sampling strategy to hold component securities or financial instruments with similar economic characteristics, weighted by market capitalization across sectors such as communication services, consumer discretionary, consumer staples, energy, financials, industrials, information technology, materials, real estate, and utilities. SPXV provides investors with targeted exposure to large-cap U.S. equities outside the health care industry, featuring quarterly distributions, options availability, a net expense ratio of 0.09% (after fee waivers through September 30, 2026), and holdings in approximately 443 companies as of late 2025, with top weights in firms like NVIDIA Corp., Apple Inc., and Microsoft Corp. Launched on September 22, 2015 and listed on NYSE Arca, the ETF is managed by ProShare Advisors LLC, a subsidiary of ProShares headquartered in Bethesda, Maryland, which was established in 1999 and specializes in innovative ETFs for risk management and return enhancement. The fund primarily serves institutional and retail investors seeking diversified, non-health care U.S. equity exposure through secondary market trading or authorized participant creations/redemptions in creation units. Geographically, it focuses on U.S.-domiciled large-cap companies, comprising about 99.5% U.S. stocks by asset allocation. Recent developments include the extension of ProShare Advisors' contractual fee waiver through September 30, 2026, reducing the net expense ratio to 0.09% from a gross of 0.13%; quarterly dividend declarations in 2025 totaling around $0.73 annually, such as $0.1672 and $0.1616 per share; and a 2-for-1 share split effective April 10, 2024 to enhance liquidity. Portfolio turnover remains low at 4% in the most recent fiscal year, reflecting stable index reconstitution every September with interim adjustments in March, June, and December; as of December 2025, assets under management approximate $3.4 billion based on recent NAV and trading volume, with no major acquisitions, partnerships, or strategic shifts reported in the prior 1-2 years beyond ongoing performance tracking and sector rebalancing amid market conditions.